A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
Public ClinicalTrials.gov record NCT04504032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Controlled, Phase 2b Study to Evaluate Safety and Efficacy of Rivaroxaban (Xarelto®) for High Risk People With Mild COVID-19
Study identification
- NCT ID
- NCT04504032
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gates Medical Research Institute
- Other
- Enrollment
- 497 participants
Conditions and interventions
Conditions
Interventions
- Rivaroxaban Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2020
- Primary completion
- Mar 9, 2021
- Completion
- Mar 28, 2021
- Last update posted
- Oct 21, 2021
2020 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland Research Northwest LLC - ERG - PPDS | Rogers | Arkansas | 72758 | — |
| Science 37, Inc | Los Angeles | California | 90094 | — |
| Allergy and Asthma Medical Group and Research Center - CRN - PPDS | San Diego | California | 92123 | — |
| Invesclinic, LLC | Fort Lauderdale | Florida | 33308 | — |
| Advanced Pulmonary Research Institute | Loxahatchee Groves | Florida | 33470 | — |
| LCC Medical Research - Miami - BTC - PPDS | Miami | Florida | 33126 | — |
| Adult Medicine of Lake County | Mt. Dora | Florida | 32757 | — |
| Providea Health Partners LLC | Evergreen Park | Illinois | 60805 | — |
| Clinical Research Institute, Inc - CRN - PPDS | Minneapolis | Minnesota | 55402 | — |
| Encompass Care | North Las Vegas | Nevada | 89086 | — |
| Riverside Medical Group - Circuit- PPDS | Secaucus | New Jersey | 07094 | — |
| Elmhurst Hospital Center | Elmhurst | New York | 11373 | — |
| Harlem Hospital Center | New York | New York | 10037 | — |
| NYC Health + Hospitals/Lincoln | The Bronx | New York | 10451 | — |
| Premier Family Physicians - Austin - Hunt - PPDS | Austin | Texas | 78735 | — |
| Village Health Partners - Plano - Hunt - PPDS | Plano | Texas | 75024 | — |
| South Texas Allergy and Asthma Medical Professionals | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04504032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04504032 live on ClinicalTrials.gov.